shortage list tirzepatide Lilly's weight-loss drug removed from FDA's Eli Lilly's Weight-Loss, Diabetes Drug

Tirzepatide is a newer medication with growing availability in Thailand, and its dual-mechanism action makes it a compelling option for patients who want more aggressive weight management under proper medical supervision

In studies, 4% to 8% of patients stopped treatment due to side effects such as nausea, vomiting, and/or diarrhea

Low insulin sensitivity may alter disease course, with patients experiencing more chronic and unstable disease, regardless of their age, weight, or medication use

Accessibility and administration considerations Transdermal patches can be an ideal choice for patients with needle anxiety or injection administration issues

Obstet Gynecol 91 : 432436